ELP3 and melanoma: Additionally, wobble U34 modifications catalyzed by ELP3/CTU1/2 have been shown to drive melanomas that express mutated BRAF, with subsequent resistance to anti-BRAF therapy caused by U34-dependent codon-biased translation of metabolic proteins [70].